Parkinson's Blog

Lars von Trier has been admitted to a care center to receive treatment for Parkinson’s disease, his production company confirms.

Lars Von Trier, known for his disturbing and stylised work, publicly revealed his diagnosis in 2022.

From a study that analyzed brain images of more than 2,500 people with Parkinson’s disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics for each of the five clinical stages of the disease.

The Italian Ambassador to Accra, Laura Ranalli, received Professor Gianni Pezzoli, director of the Parkinson’s and Parkinsonism Centre at the G. (ANSA)

PALM DESERT, Calif. (KESQ)- Parkinson’s patients and their caregivers attended the first “Parkinson’s Today:  An Educational Symposium” in Palm Desert on Saturday.  PRO or Parkinson’s Resource Organization teamed up with The Michael J. Fox Foundation for the symposium that included three panels that covered treatment, research and policy, and caregiving.  Ethan Henderson, Senior Associate Director

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD.

The conductor, 82, today confirms a long-suspected diagnosis…

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

The full results of the Exenatide-PD3 study, a phase 3 clinical trial of Type 2 diabetes drug exenatide (Bydureon), have now been published. They report

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson’s disease. The US FDA this week approved the sale of the treatment, which harnesses innovative technology to make managing the condition easier and more impactful, will be available towards the end of 2025.